Exhibit 10.1
SUMMARY OF COMPENSATION
ARRANGEMENTS
WITH NON-EMPLOYEE
DIRECTORS
The following description of the
compensation arrangements between Allos Therapeutics, Inc.
(the “ Company ”) and each of its non-employee
directors is provided pursuant to Item 601(b)(10)(iii) of
Regulation S-K, which requires a written description of any
compensatory plan or arrangement between a registrant and any of
its directors when the compensation information is not set forth in
any formal document.
The type and amount of compensation
paid or awarded to the Company’s non-employee directors is
reviewed from time to time by the Compensation Committee (the
“ Compensation Committee ”) of the
Company’s Board of Directors (the “ Board
”). In order to retain the services of the
Company’s current non-employee directors, to secure and
retain the services of new non-employee directors, and to provide
competitive compensation for such persons’ services as
directors of the Company, the Compensation Committee recommended
and the Board approved the following compensation arrangements for
the Company’s non-employee directors effective June 22,
2009:
·
The Company will pay the Chairman of
the Board an annual retainer of $60,000, and will pay each other
director an annual retainer of $40,000, such retainers to be paid
in four equal quarterly installments on the first day of each
calendar quarter.
·
The Company will pay (i) each
director who serves as Chairman of the Audit Committee of the Board
(the “ Audit Committee ”) an annual retainer of
$20,000, (ii) each director who serves as Chairman of the
Compensation Committee an annual retainer of $12,500, and
(iii) each director who serves as Chairman of any other
committee of the Board an annual retainer of $7,500, such retainers
to be paid in four equal quarterly installments on the first day of
each calendar quarter.
·
The Company will pay (i) each
director who serves as a member of the
